3-Benzyl-5-((2-nitrophenoxy)methyl)dihydrofuran-2(3H)-one (3BDO), an autophagy inhibitor, suppresses proliferation, EMT, and stemness in GBM cells by targeting survivin 166. The gene discussed is BIRC5; the disease is glioblastoma.